Paul E. McGarry's most recent trade in Rockwell Medical Inc was a trade of 37,210 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 17, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rockwell Medical Inc | Paul E. McGarry | SVP, Finance and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 37,210 | 37,210 | - | - | Stock Option (Right to Buy) | |
| Rockwell Medical Inc | Paul E. McGarry | SVP, Finance and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 28,515 | 28,515 (0%) | 0% | 0 | Common Stock | |
| Rockwell Medical Inc | Paul E. McGarry | VP, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2022 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Rockwell Medical Inc | Paul E. McGarry | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) |